Stryker Corp., US8636671013

Stryker slides, BofA trims target on medtech slowdown

22.06.2026 - 16:13:45 | ad-hoc-news.de

Stryker Corp. comes into Monday with a fresh analyst note from Bank of America. The broker cut its price target to 380 dollars from 450 and kept a Buy rating, according to Yahoo Finance.

Stryker Corp., US8636671013
Stryker Corp., US8636671013

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-22, 14:10.

Stryker Corp. (US8636671013) starts Monday with an analyst anchor on NYSE-listed shares. Bank of America cut its price target to 380 dollars from 450 on June 12 and kept a Buy rating, Yahoo Finance reported. Yahoo Finance report on the BofA note

BofA resets the bar

Bank of America’s revised target gives the Stryker stock a new reference point. The note keeps the rating in positive territory, but it narrows the upside that was previously embedded in the 450-dollar target. The source page names June 12 as the publication date.

That matters because Stryker trades on the New York Stock Exchange under the ticker SYK, which keeps the market context firmly in the US large-cap healthcare space. MarketBeat listed Stryker at 307.13 dollars at 09:52 AM Eastern, while Onvista showed 307.80 dollars for the NYSE print in euro terms on its quote page.

Monday calendar watch

Monday opens with the usual calendar view around a healthcare blue chip on the S&P 500. Simply Wall St describes Stryker as a medical technology company operating in the United States and internationally, a profile that keeps investor attention on devices, orthopedics and hospital equipment. Simply Wall St company profile

On the current quote pages, the share price sits close to 307 dollars, which gives the analyst debate a clear market backdrop. Onvista lists the stock as Medizinische Geräte and places it inside the S&P 500 reference frame, which is useful for sector comparison against larger US medtech names.

Go deeper

All news and analysis on Stryker shares

The US medtech group remains in analyst focus after Bank of America’s June 12 target cut and the latest quote checks on NYSE-listed SYK.

What Stryker sells

The company sells medical technology products for orthopedics, surgical equipment and hospital workflows. Its portfolio includes implants, instruments and equipment used in operating rooms and trauma care, which makes product launches relevant for hospital buyers.

Where the shares trade

The Stryker shares (US8636671013) trade on 2026-06-22, 14:10 on the NYSE at 307.13 dollars.

Key data on the Stryker shares

  • Company: Stryker Corporation
  • ISIN: US8636671013
  • Ticker: SYK
  • Trading venue: NYSE
  • Price (as of 2026-06-22, 09:52): 307.13 USD
  • Sector / industry: Healthcare - Medical Devices
  • Index membership: S&P 500

More on the Stryker shares in social media

Disclaimer: This article is for information only and does not constitute investment advice.

en | US8636671013 | STRYKER CORP. | boerse | 69603712 | bgmi